CC
TXG icon

Centiva Capital’s 10x Genomics TXG Stock Holding History

Centiva Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,090
Closed -$525K – 2052
2025
Q1 		$525K Buy
60,090
+39,028
+185% +$492K 0.02% 783
2024
Q4 		$302K Buy
+21,062
New +$332K 0.01% 1135
2023
Q1 		– Sell
-7,661
Closed -$279K – 1851
2022
Q4 		$279K Buy
+7,661
New +$250K 0.01% 975
2021
Q4 		– Sell
-5,799
Closed -$844K – 1550
2021
Q3 		$844K Buy
5,799
+1,532
+36% +$263K 0.05% 391
2021
Q2 		$836K Buy
+4,267
New +$772K 0.02% 644

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Centiva Capital's TXG Position: Q2 2025 in Review

Centiva Capital sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 60,090 shares — an estimated $525K sold.

Centiva Capital first reported a position in TXG in Q2 2021 and held it in 5 quarters. The position peaked at $844K in Q3 2021. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • Centiva Capital reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 60,090 10x Genomics shares in Q2 2025, an estimated $525K.
  • Centiva Capital first reported a position in 10x Genomics in Q2 2021 and held it in 5 quarters.
  • Centiva Capital's 10x Genomics position peaked at $844K in Q3 2021.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.